NYU Langone Cancer Center — New York, New York

NYU Langone Cancer Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

NYU Langone Cancer Center has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumor, Adult, Intrahepatic Cholangiocarcinoma, Urothelial Carcinoma.

Sponsors: Kinnate Biopharma, Relay Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Cancer Center?

NYU Langone Cancer Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Cancer Center conducted?

NYU Langone Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Solid Tumor, Adult, Intrahepatic Cholangiocarcinoma, Urothelial Carcinoma.

Is NYU Langone Cancer Center accredited by Crixeo Health?

NYU Langone Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.